{
    "code": "02024079",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024079",
    "time": "2017-01-27 03:28:39",
    "許可證字號": "衛署藥輸字第024079號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/10\/05",
    "發證日期": "93\/10\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202407902",
    "中文品名": "耐適恩注射劑４０毫克",
    "英文品名": "NEXIUM POWDER FOR INJECTION AND INFUSION 40MG",
    "適應症": "─用於不適合使用口服治療時之替代治療：─胃食道逆流性疾病，於食道炎及\/或有嚴重逆流症狀之病患─NSAID治療相關之胃潰瘍的治療。─於治療性內視鏡處置急性出血性胃潰瘍或十二指腸潰瘍之後預防再出血。1-18歲兒童及青少年:不適合使用口服治療時之抗胃酸分泌治療，例如:胃食道逆流性疾病，於糜爛性逆流性食道炎及\/或有嚴重逆流症狀之病患。",
    "劑型": "243凍晶注射劑",
    "包裝": "40公絲小瓶 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "ESOMEPRAZOLESODIUM"
    ],
    "限制項目": "02輸　入 54依本署89、12、12衛署藥字第0890035812號公告事項九得免除國內進行臨床試驗之特殊醫療需要之新藥",
    "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F420022000  ASTRAZENECA AB",
        "製造廠廠址": "S-151 85 SODERTALJE  SWEDEN",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5640002920",
            "成分名稱": "ESOMEPRAZOLE SODIUM",
            "含量描述": "",
            "含量": "42.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "024079-Nexium Inj 40mg-中文仿單20150629approved-104-09-16(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024079&Seq=069&Type=9"
        },
        {
            "title": "024079-Nexium IV 40mg - Carton - 1 vial-104-09-30(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024079&Seq=001&Type=8"
        }
    ]
}